Chapter 1. Placental Stem Cell Therapy for Neurological Disorders Market – Scope & Methodology
   1.1. Market Segmentation
   1.2. Scope, Assumptions & Limitations
   1.3. Research Methodology
   1.4. Primary Sources
   1.5. Secondary Sources
 Chapter 2. Global Filling Machines Market– Executive Summary
   2.1. Market Size & Forecast – (2023 – 2030) ($M/$Bn)
   2.2. Key Trends & Insights
             2.2.1. Demand Side
             2.2.2. Supply Side
   2.4. Attractive Investment Propositions
   2.5. COVID-19 Impact Analysis
 Chapter 3. Placental Stem Cell Therapy for Neurological Disorders Market – Competition Scenario
   3.1. Market Share Analysis & Company Benchmarking
   3.2. Competitive Strategy & Development Scenario
   3.3. Competitive Pricing Analysis
   3.4. Supplier-Distributor Analysis
 Chapter 4. Placental Stem Cell Therapy for Neurological Disorders Market Entry Scenario
    4.1. Regulatory Scenario
    4.2. Case Studies – Key Start-ups
    4.3. Customer Analysis
    4.5. PESTLE Analysis
    4.4. Porters Five Force Model
               4.4.1. Bargaining Power of Suppliers
               4.4.2. Bargaining Powers of Customers
               4.4.3. Threat of New Entrants
               4.4.4. Rivalry among Existing Players
                4.4.5. Threat of Substitutes
 Chapter 5. Placental Stem Cell Therapy for Neurological Disorders Market - Landscape
   5.1. Value Chain Analysis – Key Stakeholders Impact Analysis
   5.2. Market Drivers
   5.3. Market Restraints/Challenges
   5.4. Market Opportunities
  Chapter 6. Placental Stem Cell Therapy for Neurological Disorders Market – By Type
   6.1.  Introduction/Key Findings   
   6.2.  Allogeneic Placental Stem Cell Therapy
   6.3 Autologous Placental Stem Cell Therapy
   6.4 Y-O-Y Growth trend Analysis By Type
   6.5. Absolute $ Opportunity Analysis By Type, 2023-2030
 Chapter 7. Placental Stem Cell Therapy for Neurological Disorders Market – By End-User
7.1 Introduction/Key Findings
7.2 Hospitals & Specialty Clinics
7.3 Clinics Research Organizations
7.4 Research Institutes & Academics
7.5 Y-O-Y Growth trend Analysis By End-User
7.6 Absolute $ Opportunity Analysis By End-User, 2023-2030
  Chapter 8.Placental Stem Cell Therapy for Neurological Disorders Market, By Geography – Market Size, Forecast, Trends & Insights
   8.1. North America
                                8.1.1. By Country
                                               8 .1.1.1. U.S.A.
                                               8.1.1.2. Canada
                                                8.1.1.3. Mexico
                                8.1.2. By Type
                                8.1.3. By End-User
     8.1.4. Countries & Segments - Market Attractiveness Analysis
   8.2. Europe
                                8.2.1. By Country
                                                8.2.1. U.K.                         
                                                8.2.2. Germany
                                                8.2.3. France
                                                8.2.4. Italy
                                                8.2.5. Spain
                                                8.2.6. Rest of Europe
                                8.2.2. By Type
                                8.2.3. By End-User
     8.2.5. Countries & Segments - Market Attractiveness Analysis
8.3. Asia Pacific
                                8.3.1. By Country
                                                8.3.1. China
                                                8.3.2. Japan
                                                8.3.3. South Korea
                                                8.3.4. India      
                                                8.3.5. Australia & New Zealand
                                                8.3.6. Rest of Asia-Pacific
                                8.3.2. By Type
                                8.3.3. By End-User
     8.3.5. Countries & Segments - Market Attractiveness Analysis
8.4. South America
                                8.4.1. By Country
                                                8.4.1. Brazil
                                                8.4.2. Argentina
                                                8.4.3. Colombia
                                                8.4.4. Chile
                                                8.4.5. Rest of South America
                                8.4.2. By Type
                                8.4.3. By End-User
     8.4.5. Countries & Segments - Market Attractiveness Analysis
8.5. Middle East & Africa
                                8.5.1. By Country
                                                8.5.1. United Arab Emirates (UAE)
                                                8.5.2. Saudi Arabia
                                                8.5.3. Qatar
                                                8.5.4. Israel
                                                8.5.5. South Africa
                                                8.5.6. Nigeria
                                                8.5.7. Kenya
                                                8.5.8. Egypt
                                                8.5.9. Rest of MEA
                                8.5.2. By Type
                                8.5.3. By End-User
     8.5.5. Countries & Segments - Market Attractiveness Analysis
 Chapter 9. Placental Stem Cell Therapy for Neurological Disorders Market – Company Profiles – (Overview, Product Portfolio, Financials, Strategies & Developments)
9.1 Mesoblast Ltd
9.2 Pluristem Therapeutics 
9.3ReNeuron Group
9.4AthersysInc. 
9.5Cordlife India
9.6LifeCell International Pvt. Ltd
9.7Cryo-Cell International Inc. 
9.8CBR Systems
9.9Cellularity Inc. 
9.10Cynata